Variants of the <it>Matrix Metalloproteinase-2 </it>but not the <it>Matrix Metalloproteinase-9 </it>genes significantly influence functional outcome after stroke
<p>Abstract</p> <p>Background</p> <p>Multiple lines of evidence suggest that genetic factors contribute to stroke recovery. The matrix metalloproteinases -2 (MMP-2) and -9 (MMP-9) are modulators of extracellular matrix components, with important regulatory functions in...
Main Authors: | Sobral João, Krug Tiago, Manso Helena, Albergaria Isabel, Gaspar Gisela, Ferro José M, Oliveira Sofia A, Vicente Astrid M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-03-01
|
Series: | BMC Medical Genetics |
Online Access: | http://www.biomedcentral.com/1471-2350/11/40 |
Similar Items
-
Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01) -
The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
by: Jacek Kudelski, et al.
Published: (2023-03-01) -
Clinical significance of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and 2 in Kawasaki disease
by: Ki Wook Yun, et al.
Published: (2010-04-01) -
Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome
by: Asma Laroui, et al.
Published: (2022-09-01) -
Expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in recurrent chronic rhinosinusitis with nasal polyposis
by: Ling-Feng Wang, et al.
Published: (2013-01-01)